Results 101 to 110 of about 30,205 (229)

Key Features of Contemporary Pilot and Feasibility Trials: Protocol for a Methodological Study

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 5, May 2026.
ABSTRACT Background Randomised clinical trials (RCTs) are costly undertakings requiring careful design, planning and conduct. Failure to achieve timely participant recruitment, separation between intervention groups and adequate follow‐up contributes to waste in research.
Aske Tøgern, Morten H. Møller, Anders Perner, Maj‐Brit N. Kjær, Ruben J. Eck, Carl T. Anthon, Jehad A. Barakji, Anders Granholm   +7 more
wiley   +1 more source

Venous thromboembolism risk following surgery during the COVID‐19 pandemic

Anaesthesia, Volume 81, Issue 5, Page 637-645, May 2026.
Summary Introduction SARS‐CoV‐2 infection is associated with an increased risk of venous thromboembolism. Data are lacking on how this risk altered during the COVID‐19 pandemic and following vaccination. We aimed to evaluate the 90‐day risk of postoperative venous thromboembolism during the pandemic. Methods We performed a retrospective cohort study of
Andrew Jackson, David J. Humes, Amir Mehrkar, Sebastian C. J. Bacon, Simon Davy, Ben Goldacre, Joe West, Colin J. Crooks   +7 more
wiley   +1 more source

Effectiveness and Safety of Long-Term Venous Thromboembolism Prophylaxis After Colorectal Cancer Surgery: A Retrospective Study

Drugs - Real World Outcomes
Background The optimal duration for thromboprophylaxis after colorectal cancer surgery remains uncertain. We sought to compare the effectiveness and safety of long-term thromboprophylaxis to that of short-term thromboprophylaxis in preventing venous ...
Ying Zhang, Xiaozhu Zhou, Yi Wu, Shicai Chen, Xiangli Cui, Ying Zhao   +5 more
doaj   +1 more source

Global Thrombosis Test - a possible monitoring system for the effects and safety of dabigatran [PDF]

, 2015
© Otsui et al. 2015BACKGROUND: Dabigatran is an alternative to warfarin (WF) for the thromboprophylaxis of stroke in patients with non-valvular atrial fibrillation (NVAF). The advantage of dabigatran over WF is that monitoring is not required; however, a
Gorog, Diana A, Inoue, Nobutaka, Iwata, Sachiyo, Otsui, Kazunori, Ozawa, Toru, Suzuki, Atsushi, Takei, Asumi, Yamamoto, Junichiro, Yoshioka, Takayuki   +8 more
core   +2 more sources

Multiple consecutive daily therapeutic plasma exchange using exclusively albumin replacement fluid in low bleeding risk patients is associated with only rare and mild bleeds

Transfusion, Volume 66, Issue 5, Page 903-909, May 2026.
Abstract Background Therapeutic plasma exchange (TPE) using exclusively albumin replacement fluid depletes coagulation factors, particularly fibrinogen, and concerns about performing multiple consecutive daily procedures due to iatrogenic bleeding exist. Fibrinogen testing to guide bleeding risk stratification is vague.
Jay S. Raval, Joseph R. Griggs, Andres E. Mindiola Romero, Chelsea Reyes, Sarah Mertens, Cynthia Ornelas, Lizabeth Marinaro, Marian A. Rollins‐Raval   +7 more
wiley   +1 more source

An update on prevention of venous thromboembolism in hospitalized acutely ill medical patients

Thrombosis Journal, 2006
Both the recently updated consensus guidelines published by the American College of Chest Physicians, and the International Union of Angiology recommend thromboprophylaxis with either low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH) in
Kleber Franz-Xaver, Samama Meyer
doaj   +1 more source

Impact of risk factors on the timing of first postpartum venous thromboembolism: a population-based cohort study from England [PDF]

, 2014
For women with preeclampsia, BMI >30 kg/m2, infection, or those having cesarean delivery, VTE risk remained elevated for 6 weeks postpartum.For women with postpartum hemorrhage or preterm birth, the relative rate of VTE was only increased for the ...
Abdul Sultan, Al-Zirqi, Alyshah Abdul Sultan, Bates, Berkowitz, Cantwell, Carroli, Catherine Nelson-Piercy, Dattani, Douglas, Drife, Eaton, Friedman, Gibbons, Heit, Jacobsen, Jacobsen, James, Joe West, Kamel, Kate M. Fleming, Laila J. Tata, Larsen, Lawrenson, Lindqvist, Lindqvist, Lindqvist, Lucas, Matthew J. Grainge, Morris, Rodger, Royal College of Obstetricians and Gynaecologists, Salonen Ros, Schmidt, Simpson, Själander, Smeeth, Sultan, Sultan, Tepper, Victora, Walker, Zhang   +42 more
core   +1 more source

IgG-class anti-PF4/heparin antibodies and symptomatic DVT in orthopedic surgery patients receiving different anti-thromboembolic prophylaxis therapeutics [PDF]

, 2011
Background Heparin-induced thrombocytopenia (HIT) is a thromboembolic complication that can occur with unfractionated heparin (UFH) or low molecular weight heparin (LMWH).
Satoru Motokawa, Takafumi Torigoshi, Yumi Maeda, Kazushige Maeda, Yuka Jiuchi, Takayuki Yamaguchi, Shinsuke Someya, Hiroyuki Shindo, Kiyoshi Migita   +8 more
core   +1 more source

Establishment of prophylactic enoxaparin dosing recommendations to achieve targeted anti-factor Xa concentrations in children with CHD [PDF]

, 2018
Background Enoxaparin may be used to prevent central venous catheter-related thrombosis in patients with CHD. We aimed to determine whether current enoxaparin dosing regimens effectively achieve anti-factor Xa concentrations within prophylactic goal ...
Israel, Emily N., Mastropietro, Christopher W., Thomas, Christopher A.   +2 more
core   +1 more source

Venous Thromboprophylaxis in Spine Surgery

Global Spine Journal, 2020
Study Design: Review article. Objective: A review of the literature on postoperative initiation of thrombophylactic agents following spine surgery.
Anthony M. Alvarado MD, Guilherme B. F. Porto MD, Jeffrey Wessell DO, Avery L. Buchholz MD, MPH, Paul M. Arnold MD   +4 more
doaj   +1 more source